A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

• Patrick A. Ott,

  Affiliation Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Anne Hamilton,

  Affiliations Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia, Sydney Melanoma Unit and University of Sydney, Sydney, Australia

  ⨯
• Christina Min,

  Affiliation Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Sara Safarzadeh-Amiri,

  Affiliation Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Lauren Goldberg,

  Affiliation Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Joanne Yoon,

  Affiliation Department of Dermatology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Herman Yee,

  Affiliation Department of Pathology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Michael Buckley,

  Affiliation Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Paul J. Christos,

  Affiliation Division of Biostatistics and Epidemiology, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• John J. Wright,

  Affiliation Investigational Drug Branch, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• David Polsky,

  Affiliations Department of Pathology, New York University School of Medicine, New York, New York, United States of America, Department of Dermatology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Iman Osman,

  Affiliations Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America, Department of Dermatology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Leonard Liebes,

  Affiliation Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Anna C. Pavlick

  * E-mail: anna.pavlick@nyumc.org

  Affiliations Department of Medical Oncology, New York University School of Medicine, New York, New York, United States of America, Department of Dermatology, New York University School of Medicine, New York, New York, United States of America

  ⨯